Completion Dissection or Observation for Sentinel-Node Metastasis in MelanomaMark B. Faries, Robert M. Elashoff, Richard Hoefer et al.|New England Journal of Medicine|2017Cited by 1.4k
Results of a Phase III, Randomized, Placebo-Controlled Study of Sorafenib in Combination With Carboplatin and Paclitaxel As Second-Line Treatment in Patients With Unresectable Stage III or Stage IV MelanomaAxel Hauschild, Ulrich Keilholz, Sanjiv S. Agarwala et al.|Journal of Clinical Oncology|2009Cited by 545
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trialAlexander Eggermont, B. Guillot, Paul Lorigan et al.|The Lancet Oncology|2021Cited by 389
Inducible but Not Constitutive Expression of PD-L1 in Human Melanoma Cells Is Dependent on Activation of NF-κBKavitha Gowrishankar, Peter Hersey|PLoS ONE|2015Cited by 221
Mcl-1, Bcl-XL and Stat3 expression are associated with progression of melanoma whereas Bcl-2, AP-2 and MITF levels decrease during progression of melanomaLiqing Zhuang, Peter Hersey|Modern Pathology|2007Cited by 196